Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Absolute bioavailability and pharmacokinetics study of S 47445 in healthy male volunteers
NL-OMON34318Active, not recruiting
- Sponsor
- Servier
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tulrampator in Alzheimer's disease (AD), sponsored by Servier. Primary endpoints: Plasma S 47445 concentrations, Urine S 47445 concentrations and 3 more. Started Nov 2010; status: active, not recruiting.
02
Drugs
tulrampator
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NL-OMON34318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34318.